Belantamab mafodotin, CAS 2050232-20-5

Product Description: Belantamab mafodotin (GSK2857916) is composed of humanized and focused monoclonal antibody against B cell maturation antigen (BCMA) and McMMAF. Belantamab mafodotin has anti-myeloma activity[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Hulin C, et al. Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study. Lancet Oncol. 2020 Feb;21(2):207-221./[2]Markham A. Belantamab Mafodotin: First Approval. Drugs. 2020 Oct;80(15):1607-1613.

CAS Number: 2050232-20-5

Molecular Weight: 149000 (average)

Compound Purity: 99.60

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Antibody-Drug Conjugates (ADCs)

• Artikelnummer: MEXHY-P3239-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P3239-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK